Fernit..... you forget one thing.
With a new drug treating a previously untreated disease, of course there needs to be a comparison, 'the control', to show the efficacy of said new drug/treatment.
However stroke has been with us for a long long time so the control has been studied also for that very long long time. The medical professionals knows the timescales, improvement cycles and markers for untreated or currently available treatment for recovery from stroke...... That's their control.
If afamelanotide reduces that timescale and/or improves the recovery, then that is a win in my view.
In other words, they already have decades of 'control' patients.
GLA
- Forums
- ASX - By Stock
- CUV
- Ann: Positive Final Results in Stroke Study CUV801
Ann: Positive Final Results in Stroke Study CUV801, page-24
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.30 |
Change
0.000(0.00%) |
Mkt cap ! $716.1M |
Open | High | Low | Value | Volume |
$14.21 | $14.33 | $13.69 | $2.607M | 186.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 658 | $14.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.32 | 698 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70 | 14.000 |
1 | 1080 | 13.880 |
1 | 415 | 13.850 |
1 | 690 | 13.760 |
1 | 2000 | 13.750 |
Price($) | Vol. | No. |
---|---|---|
14.320 | 698 | 1 |
14.340 | 1000 | 1 |
14.370 | 100 | 1 |
14.460 | 1000 | 1 |
14.490 | 132 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |